Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,245 across all filing types
Latest filing 2023-10-10 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2023. It is addressed to the National Stock Exchange of India Limited and is a compliance certificate from the Registrar and Share Transfer Agent. The document does not contain financial statements or substantive financial data but is a regulatory compliance certificate. It is not an annual or interim report, nor an earnings release or management discussion. It is a regulatory filing related to securities regulations and compliance.
2023-10-10 English
Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities ....
Regulatory Filings
2023-10-10 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of shares under an Employee Stock Options Plan (ESOP). It details the number of shares allotted, the increase in issued share capital, and compliance with SEBI regulations related to share-based employee benefits. There are no financial statements, earnings data, or management discussion. The document is an announcement of a capital change due to ESOP share allotment, fitting the category of Share Issue/Capital Change (SHA). The document length is 4429 characters, which is sufficient for a detailed announcement rather than a brief notice. Therefore, the appropriate classification is SHA.
2023-10-09 English
We would like to inform that, the ESOP Allotment Committee of the Company at its meeting held on October 09, 2023, has approved the allotment of 2,74,150 equity shares of face value of ....
Share Issue/Capital Change Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the allotment of shares under an Employee Stock Options Plan (ESOP). It details the number of shares allotted, the increase in issued share capital, and compliance with SEBI regulations related to share-based employee benefits. There are no financial statements, earnings data, or management discussion; rather, it is an announcement of a capital change due to ESOP share allotment. This fits the category of Share Issue/Capital Change (SHA). The document length is 4429 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is SHA with high confidence.
2023-10-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) informing about the closure of the trading window for insiders and designated persons due to upcoming unaudited financial results for the quarter and half year ended September 30, 2023. It references regulatory compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The document does not contain any financial data or results itself, nor does it present a report. It is an announcement related to trading restrictions ahead of financial results disclosure. The document length is short (2016 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2023-09-29 English
This is to inform you that pursuant to the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) informing about the closure of the trading window for insiders and designated persons due to upcoming unaudited financial results for the quarter and half year ended September 30, 2023. It references regulatory compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The document does not contain any financial data or results itself, nor does it provide detailed financial analysis or report. It is an announcement related to trading restrictions ahead of a financial results announcement. The document length is short (2016 characters), and it serves as a notification rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-09-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.